New research reveals that shifts in glucose metabolism critically regulate the differentiation and fate of naive CD4+ T lymphocytes upon activation. These findings elucidate metabolic underpinnings of adaptive immunity and could inform novel immunotherapeutic strategies. By dissecting the metabolic pathways directing CD4+ T cell responses, the study advances understanding of immune modulation in the context of infection and disease.